<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 128 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page127.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=128">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 128 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 128</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=128"><img src="../thumb/128.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.3.3                                                  2020-04 / 97
       duct.inhibits., at least 48 hrs.to elapse betw.last dos.& surg.if ther.  of discont. the other, IV admin.of Ca antagon./anti-dysrhythm.   fibros., pleurisy, resp.distress incl. ac.interstit.pneumonit.& pulm.
       withdr.bef. anaesth., halog.inhal.anaesthet., peri-op per., tachycard.  agents to be avoid., alpha-adrenerg. block. pre-treatm.usual.reqd.  oed., GI disturbs., hepatotox., rais.liv.enzymes, jaund., pancreatit.,
       respons.poss.obscur.due to hypovolaem. / bld.loss, concom.vera-  in phaeochromocyt., cont. lens., clonidine transf., monit.pulse rate   hyperuricaem., skin rash, psorias. exacerbat., perspirat., alopec.,
       pamil in imp.ventr.funct.& neith.to be giv.with.48 hrs.of discont.the   & pt. response in CCF pts.with concom.digox., decr.urin. Ca excret.  photosens., back-/ joint-/chest pain, musc.cramps, myopathy, skelet.
       other, prior alpha-adrenerg.block.in phaeochromocyt., pulse rate &   may result in intermit.slight.rais.ser.Ca, mark. hypercalcaem.poss.  musc.weakn., decr.sex.ability, male impot.
       respons.to be monit.in CCF pts.if digox. used concom., grad.withdr.&   evid.of underly. hyperparathyroid., hyperuricaem.&/gout precipit.,   Special precautions: Do not withdr.abrupt.in ischaem.heart dis.,
       phys.activ. limit.dur.withdr.per., clonidine transf., psorias.pts., myasth.  sulfonam./ penicill.allerg.hist., discont.treatm.in case of idiosyncrit.  at least 48 hrs.to elapse betw. last dos.& surg.if ther.to be withdr.
       grav.poss.unmask., cont.lens., ang.pect. exacerbat.in ischaem.heart   react.result.in ac.trans.myop.& ac. angl.-clos.glauc., concom.Ca   bef. anaesth., concom.ether/cycloprane/ trichloroethylene dur.anaes-
       dis.with abrupt withdr.       chann.block.not to be giv., cross.placenta & appears in breast milk,   thes., maint.usual dos. peri-op., tachycard.respons.poss.obscur., ren.
       Interactions: Potent.eff.of other concom. antihypertens., poss.  poss. incr.sens.to allerg.& anaphylact.reacts.with adrenal. somet.  impairm., elderly, concom.Class 1 antidysrhythm. agents/myocard.
       addit.syst.eff.with topic.ß-block. eye drops, imp.antihypertens.eff.  not hav.expect.eff., ang.pect. exacerbat. with abrupt discont.in   depress./ AV conduct. inhibits., concom. verapamil in imp. ventric.
       with NSAID’s, concom.hypoglycaem.agents/ phenothiaz. /vari-  ischaem.heart dis., limit.physic.activ.monit.dur.withdr.per., psorias.   funct.& neith.to be admin.IV within 48 hrs. of discont.the other, alpha-
       ous antidysrythm.agents poss.life threat., ß-adrenocept.stimulat.  pts., hepat.impairm./progress.liv.dis., elderly.  adrenerg. block. pre-treatm.usual.reqd.in phaeochromocytoma, diab.
                                                    +
       agents may antagon. effs., poss.life-threat.vasoconstrict.with alpha   Drug interactions: Thiazide induc.K -deplet. worsen.quinid,-  mellit.as hypoglycaem. S&S.poss.mask./respons.to hypoglycaem.
       adrenocept.stimul./adrenerg.neurone block. agents, rifampicin/bar-  induc.torsad.de point., orthostat. hypotens. potent.by alcoh./  poss.dimin., poss.delay.recov. from insul.-induc.hypoglycaem., monit.
       bits.poss.short.half-life, incr.half-life with strong hepat.cytochrome   barbitur.& narcot., concom. corticoster./ACTH intensify electrol.  pulse rate & pt.response in CCF pts.with concom. digox., poss.dos.
       P450 isoenzym. inhibit.       deplet & hypokalaem., decr.respons.to press.amin., NSAID reduc.  adjustm.of antidiabet. meds., concom. mefloquine, concom.Ca chan.
                                     antihypertens.effs., sev. hyponatraem. with trimethoprim/car-  block. verapamil & diltiazem, hydrochlorothiazide cross. placenta &
       BISOHEXAL, 5, 10, Sandoz [PWR]  bamazepine, other antihypertens. effs.potent., HF worsen.by centr.   excret.in breast milk, grad. withdr.& limit.phys.activ.dur.withdr.per.,
       Bisoprolol fumarate           act. antihypertens.agents e.g. methyldopa, half-life short.by strong   electrol. imbal., decr.urin.Ca excret.may result in intermit.slight.rais.
       Indications: Mild to mod.hypertens., ang.pect.  hepat.cytochrome P450 isoenzym. induc. (CYP 3A4 & 2D6), half-life   ser.Ca but mark. hypercalcaem.poss.evid.of underly. hyperparathy-
       (S3) TABS. 37/5.2/0516, 0517  incr.by strong hepat. cytochrome P450 isoenzym.inhibit.(CYP 3A4 &   roid., clonidine transf., poss.incr. sensitiv.towards allerg.& anaphy-
       704132-001: 5 mg, 30, R63,81  2D6), add.syst.S/E with topic.B-block.eye drops, concom. hypogly-  lact.reacts. with adrenal.not always hav.expect.eff.
       704133-001: 10 mg, 30, R107,69  caem.agents/phenothiaz./various anti-dysrhythm. agents poss.  Drug interactions: Concom.hypoglycaem. agents/phenothiaz./
       Dosage: Adults: Indiv. 5 -10 mg once dly.in the morn. Max.recomm.  life threat., ß-adrenocept. stimulat.agents may antagon.effs., poss.   various anti-dysrhythm. agents poss.life threaten., ß-adrenocept.
       dly.dos: 20 mg                life-threat.vasoconstrict.with alpha adrenocept. stimul./adrenerg.  stimulat. agents may antagon.effs., poss.life-threat. vasoconstrict.
       Contraindications: Uncontroll.bronch.asthma, 2nd & 3rd degr.heart   neur.block.agents, incr. responsiven.to neuromusc.block.  with alpha adrenocept. stimul./ adrenerg.neurone block.agents,
       block & bradycard., cardiogen. shock, sick sinus syndr., sino atrial   hydrochlorothiazide enhanc.digox.toxic., responsiven.to competit.
       block, symptomat.hypotens., periph.arter.occlus. dis/ Raynauds syn-  BISOPROLOL UNICORN, Unicorn [N/P/S in C in only certain   neuromusc.block.incr., orthostat. hypotens.potent.by alcoh./
       dr., pregn.& lactat., uncontr.card. fail., metabol.acidos., sinus brady-  sports]  barbitur.& narcot., corticoster./ACTH/digox./beta 2-adrenerg. agon./
       card.(less than 50 bpm), phaeochromocyt., hyperthyroid., safety &   Bisoprolol fumarate   carbenoxolone/amphoteric & reboxetine intensify electrol.deplet
       effic. in childr.not est., concom.verapamil.with conduct. abnormalit.  Indications: Mild to mod.hypertens., ang.pect.  & hypokalaem., decr.respons.to press.amines but not suffic. to
       Side effects: Bld.disords., CV effs.incl.heart block, periph. vasc.dis   (S3) TABS, 38/5.2/0050, 0052  preclude their use, NSAID reduc. antihypertens. effs., incr.brady-
       exacerbat., CNS effs., paradoxic. hypertens., paraesthes., metabol.   716167-001: 5 mg, 30, R53,87  card.with mefloquine, half-life short.by strong hepat. cytochrome
       disturbs., hypoglycaem., incr.uric acid, hypercholesterolaem., GI dis-  716166-001: 10 mg, 30, R93,30  P450 isoenzymes induc.(CYP 3A4 & 2D6), half-life incr.by strong
       turbs., rais.liv.enzym., musc.cramps, myopathy, skelet.musc. weakn.,   Dosage: Adults: Indiv. 5 -10 mg once dly.in the morn. Max.recomm.  hepat.cytochrome P450 isoenzymes inhibit.(CYP 3A4 & 2D6), eff. of
       vis.disturbs., skin reacts., trans.hear.loss, hypersens.reacts., sex. im-  dos: 20 mg dly.  other antihypertens.potent.
       pot., bronchoconstrict.in pts.with pulm.dis., floppy inft.syndr.if admin.  Contra-indications: Uncontroll.asthma, 2nd & 3rd degr.heart block
       shortly bef. birth/ dur.labour.  & bradycard., pregn.& lactat., uncontr.card.fail., metabol.acidos., si-  CARDICOR, (Biopharma Div) Merck [PWR] &
       Special precautions: Asthma, bronchit., chron. resp. dis., periph.  nus bradycard. (less than 50 bpm), phaeochromocyt., hyperthyroid.,   Bisoprolol fumarate.
       vasc.dis., Raynaud’s phenom., elderly, ren.dysfunct., periop peroid,   safety & effic.in childr.not est., concom.verapamil in conduct.abnor-  Indications: Stable chron.mod.to sev.HF with reduc. systol.ventric.
       diab.mellit., anaesth./ surg., concom.Class 1 antidysrhythm. agents/   malit., concom. IV Ca antagon.& antiarrythm.agents not recomm.  funct.in addit.to ACE inhibit., diuret.& optional card.glycos.
       myocard.depress./AV conduct.inhibits., clonidine transf., concom.  Side-effects: Bld.disords., CV effs.incl.CCF/ heart block/periph.  (S3) TABS, 36/6.1/0457, 0458, 0459
       verapamil.in pts.with imp. ventric.funct., concom.IV Ca antagon.&   vasc.dis.exacerbat./Raynaud’s phenom./ periph.gangrene poss.   704439-001: 2,5 mg, 30, R123,33
       antiarrythm. agents not recomm., tachycard.assoc. with hypogly-  precipit., CNS eff. incl.hallucin., paradoxic. hypertens., paraesthes.,   704440-001: 5 mg, 30, R129,77
       caem.modif., alpha-adrenerg.block. treatm. in phaeochromocytoma,   psychos., metabol. disturbs., hypoglycaem., hypercholesterolaem., GI   704441-001: 10 mg, 30, R205,22
       concom.digox.in CCF, grad.withdr., limit.phys.activ.dur.withdr.per.  disturbs., stomatit., mass gain, hepatotoxic., back/joint/chest pain,   Dosage: Titr.dos. Admin.once dly. Init.1,25 mg once dly x1wk. If well
       Drug interactions: Poss.life-threat.with hypoglycaem. agents/  musc. cramps, myopathy, skelet.musc.weakn., dry/sore eyes, vis.dis-  tol.incr.in 1,25 mg increm.at wkly interv.to 5 mg. Dos.of 5 mg once
       phenothiazines & var.anti-arrhythm. agents, ß-adrenocept.stimulat.  turbs., skin reacts., alopec., bronchoconstrict. /bronchosp.in asthma/  dly.to be maint. x4 wks.& if well tol.incr.to maint.dos.of 10 mg. Max.
       agents may antagon.effs., life threaten.vasoconstrict.with alpha-   bronchit./ other chron.pulm. dis., sex.impot., hypersens. reacts., nas.  recomm.dos: 10 mg once dly.
       adrenocept.stimul.& adrenerg.neurone block. agents  congest., trans.hear.loss, floppy inft. syndr. if admin.to mothers shortly   Contraindications: Ac.HF/episod.of HF decompensat. requir.IV
                                                                                  rd
                                                                                nd
                                     bef.birth/dur. labour, poss.ang. pect.exacerbat.with abrupt withdr.,   inotrop.ther., cardiogen. shock, 2 /3  degr.AV block without pace-
       BISOPROLOL CO UNICORN, Unicorn  tachycard.assoc.with hypoglycaem.modif.  mak., sick-sinus syndr., sinoatrial block, bradycard.of &lt;60 bpm. bef.
       Bisoprolol fumarate 5(10) mg, hydrochlorothiazide 6,25(6,25) mg   Special precautions: Asthma, bronchit., chron. resp.dis., periph.  start.ther., hypotens., sev.bronch.asthma/ COPD, advanc.periph.arter.
       Indications: Hypertens.in pts.stabilis.on indiv. compon.giv.in   vasc.dis., Raynaud’s phenom., elderly, sev.ren.dysfunct., periop per.,   occlus.dis., Raynauds, untreat. phaeochromocyt., metabol.acidos.,
       same proport.                 diab.mellit. as hypoglycaem. S&S.poss.mask./respons.to hypogly-  safety & effic.in childr.not est., concom.IV Ca antagon.& antiarrhythm.
       (S3) TABS, 46/7.1.3/0387, 0388  caem.poss.dimin., at least 48 hrs.to elapse betw.last dos.& surg.  agents, pregn., lactat.
       721588-001: 5/6,25 mg, 28, R107,72  if ther.to be withdr. bef. anaesth., concom.ether/cycloprane/ trichlo-  Side effects: CNS effs., perspirat., skin rash, allerg. reacts., alopec.,
       721589-001: 10/6,25 mg, 28, R107,72  roethylene dur.anaesthes., maint.usual dos. peri-op., tachycard.re-  bradycard., heart block, fluid retent., cold extremit., hypotens., paraes-
       Dosage: Adults: Init. one 2,5/6,25 mg tab.dly. Anoth. formul.to be   spons.poss.obscur., concom. Class 1 antidysrhythm. agents/myocard.  thes., paradox. hypertens., exacerbat.of periph.vasc.dis., Raynauds,
       used. Subseq.dos.adjustm.as appropr.up to max.recomm.dos.of one   depress./ AV conduct.inhibits., clonidine transf., concom. verapamil   GI disturbs., trans.hear.loss, bld. disords., musc.cramps, myopathies,
       10/6,25 mg tab.dly.           in imp.ventric.funct.& neith.to be admin. IV within 48 hrs.of discont.  mass gain, metabol. disturbs., overt psychos.
       Contraindications: Other sulphonamide deriv. agent hypersens.,   the other, alpha-adrenerg. block.treatm.usual.reqd.in phaeochromo-  Special precautions: Asthma, bronchit., chron. resp. dis., concom.in-
       2nd & 3rd degr.heart block, bradycard. (less than 50 bpm), pregn.&   cytoma, grad.withdr., limit.phys. activ. dur.withdr.per., monit.pulse   halat.anaesthet., diab.mellit., strict fast., densensitisat.ther., 1  degr.AV
                                                                                           st
       lactat., cardiogen. shock, uncontr.CF, sev.hypotens. (systol.BP &lt;100mm   rate & pt. response in CCF pts.with concom.digox.  block, Prinzmetal ang., periph.arter.occlus.dis., psoriasis, may mask thy-
       Hg), metabol.acidos., sinus bradycard., phaeochromocyt., hyperthy-  Drug interactions: Concom.hypoglycaem. agents/ phenothiaz./   rotoxicos.sympts., grad.withdr., peri-op period, concom.class 1 antidys-
       roid., bronchosp., asthma, bronchit./chron.resp.dis.hist., late stage   various anti-dysrhythm. agents poss.life threaten., ß-adrenocept.   rhythm.agents, concom. verapamil in imp.ventric.funct., clonidine transf.,
       periph.vasc.dis., Raynauds, Addisons dis., sev.ren/hepat.impairm.,   stimulat.agents may antagon.effs., poss.life-threat. vasoconstrict.   hypoton.newborn if admin.short.bef.birth, incr. sensitiv.to allerg.& sev.of
       where encepalopathy precipit., porphyr.  with alpha adrenocept.stimul./ adrenerg.neurone block.agents  anaphylact.reacts., No exper.in HF pts.with NYHA II heart fail.,/IDDM/
       Side effects: Ang.pect.exacerbat.poss.in ischaem. heart dis.   imp. ren.or liv.funct./&gt;80 yrs./restrict. cardiomyopathy /congenit.heart
       with abrupt discont., gluc.tol. impairm., bld.dyscras., hypo-/hyper-  BISOZYD CO, Zydus  dis./ haemodynamic. signific.organ.valvul.dis./within 3 mnths. of MI.
       glycaem., glycosur., anaphylax., pancreatit., sialadenit., metabol.   Bisoprolol fumarate 2,5(5; 10)mg, hydrochlorothiazide 6,25(6,25;   Drug interactions: Concom.hypoglycaem.agents, phenothiaz. & var.
       disturbs., hypercholesterolaem., electrol. imbal. incl.hyponatraem.,   6,25)mg   anti-arrythm.agents poss. danger., enhanc.eff.of myocard.depress.e.g.
       anorex., psych./eye disords., CNS effs., drowsin., dizzin., headache,   Indications: Hypertens.  lignocaine, procainamide & quinidine, vasoconstrict. eff.poss. dan-
       restlessn., fev., xanthops., trans.hear.loss, vertigo, bradycard., CHF,   (S3) TABS, 43/7.1.3/0059, 0060, 0061  ger.enhanc.by alpha-adrenocept. stimul., eff.poss.enhanc.by adren-
       heart block, dysrhythm., fluid retent., reduc. periph.circulat., or-  718082-001:2,5/6,25 mg, 30, R98,15  erg. neurone block.agents, half-life short.by rifampicin, addit. effs.
       thostat.hypotens., paradox. hypertens., periph.vasc.dis.exacerbat./   718086-001: 5/6,25 mg, 30, R103,14  of other ß-block.incl.eye drps., reduc. heart rate & incr.AV conduct.
       Raynaud’s phenom., periph.gangr., necrotis. vasculit., allerg.rhinit.,   718087-001: 10/6,25 mg, 30, R105,50  time with card. glycos, decr.hypotens.eff.with prostagland. synthet.
       nas.congest., bronchoconstrict. in asthma/bronchit./other chron.  Dosage: Adults: Init.one 2,5/6,25 mg tab.dly. Subseq. dos.adjustm.  inhibit., exacerbat.of periph.circulat. disturb. with ergotam.derivat.,
       pulm.dis., resp. distress incl.ac.interstit.pneumonit.& pulm. oed.,   as appropr.up to max. recomm. dos.of one 10/6,25 mg dly.  sympathomimet. agent combinat.poss reduc both agents effs., incr. BP
       GI /vis.disturbs., mass gain, stomatit., hepatotox., rais.liv.enzym.,   Contraindications: Other sulphonamide deriv.agent hypersens.,   low.eff.with TCA’s,/barbit./phenothiaz & other antihypertens. agents,
       jaund., skin reacts.incl. activ. /psorias.worsen., alopec., photosens.,   bronchoconstrict., asthma, obstruct.airway dis.hist., 2nd & 3rd degr.   incr.bradycard.risk with mefloquine, MAOI (except.MAO-B inhibit.)
       back/ joint/ chest pain, musc.cramps/spasm, myopathy, skelet.   heart block, bradycard.(less than 50 bpm), pregn. & lactat., cardiogen.  enhanc. hypotens. eff.but also risk hypertens.crisis.
       musc. weakn., hyperuricaem., ren.dysfunct. / fail., interstit.nephrit.,   shock, uncontr.card. fail., hypotens.(systol.BP &lt;100mm Hg), porphyr.,   See also MDR page 488.
       glycosur., decr.sex.abilit., sens. reacts.with/without allerg.hist./  Addisons dis., sev.ren.impairm., anur., sev. hepat.impairm., metabol.
       bronch. asthma, SLE, incr.triglycerid.lev., incr.sens.to allerg./   acidos., phaeochromocyt., hyperthyroid., safety & effic. in childr. not   CONCOR, (Biopharma Div) Merck [PWR]
       anaphylact.reacts.            est., late stage periph.vasc.dis., Raynauds.  Bisoprolol fumarate.
       Warnings and special precautions: Safety & effic. in childr.  Side effects: Bld.disords., hypersens.reacts. incl. anaphylact.re-  Indications: Mild to mod.hypertens., ang.pect.
       und.12 yrs.not est., at least 48 hrs. to elapse betw.last dos.&   acts., SLE, asymptomat.incr. in antinucl.antibod., siloadenit., hypo-/  (S3) TABS, V/5.2/303, 304
       surg.if ther.to be withdr. bef. anaesth., concom.ether/cycloprane/   hyperglycaem., hypercholesterolaem., electrol. imbal., anorex., psych.  818429-003: 5 mg, 30, R126,18
       trichloroethylene anaesthes., peri-op per., diab.mellit.as hypo-  disords., psychos.& hallucinat., CNS effs.incl.coma & convuls., decr.   818437-006: 10 mg, 30, R199,54
       glycaem. S&S poss.mask., poss.delay.recov. from insul.-induc.  tear product., conjunctivit., eye soren., vis. disturbs., trans.hear.loss,   Dosage: Indiv. 5 mg dly.in the morn., may be incr. to 10 mg if necess.
       hypoglycaem., potent.life-threat. react.with concom.quinidine,   bradycard., CHF, heart block, dysrhythm., fluid retent., reduc. periph.   Dos.of 20 mg dly.may be necess. Max.dly dos.of 10 mg in sev.ren.&
       tachycard.respons. due to hypovolaem./bld.loss.poss.obscur.dur./   circulat., orthostat.hypotens., periph. vasc. dis.exacerbat./Raynaud’s   hepat. impairm.
       aft.surg., ren.impairm., concom.Class 1 anti-dysrhythm. agents,   phenom./ periph. gangrene poss.precipit., incl.hallucin., paradoxic.   Contraindications: Uncontrol.card.fail.excl.that due to hypertroph.
       concom.verapamil in pts.with imp. ventr.dysfunct.& not to be   hypertens., necrotis.vasculit., bronchoconstrict.in asthma/bronchit./  obstruct cardiomyopathy, pregn., lactat., metabol.acidos., sinus brady-
       giv.in conduct. abnorm. & neith. meds.to be admin.with.48 hrs.  other chron. pulm.dis., allerg.rhinit., nas.congest., pneumonit., pulm.  card., concom. verapamil with conduct.abnorm.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page127.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page123.html">123</a>&nbsp;&nbsp;&nbsp;<a href="page124.html">124</a>&nbsp;&nbsp;&nbsp;<a href="page125.html">125</a>&nbsp;&nbsp;&nbsp;<a href="page126.html">126</a>&nbsp;&nbsp;&nbsp;<a href="page127.html">127</a>&nbsp;&nbsp;&nbsp;<a href="page128.html">128</a>&nbsp;&nbsp;&nbsp;<a href="page129.html">129</a>&nbsp;&nbsp;&nbsp;<a href="page130.html">130</a>&nbsp;&nbsp;&nbsp;<a href="page131.html">131</a>&nbsp;&nbsp;&nbsp;<a href="page132.html">132</a>&nbsp;&nbsp;&nbsp;<a href="page133.html">133</a>
             </td>
             <td width="35%"><a href="page129.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page129.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
